NFKB1 and nonpapillary renal cell carcinoma: In this study, we have determined that NF-κB is constitutively active in the majority of ccRCC samples tested, and have shown by meta-analysis that key NF-κB regulators and targets are uniformly up-regulated across four independent studies.